The efficacy of FDG-PET for the management of esophageal cancer

H Kato, M Nakajima - Annals of Thoracic and Cardiovascular …, 2012 - jstage.jst.go.jp
18F-Fluorodeoxyglucose positron emission tomography has become an important
informative modality during the past two decades. Because this type of tomography is a …

The clinical application of 18F‐fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer

H Kato, M Nakajima, M Sohda… - … Journal of the …, 2009 - Wiley Online Library
BACKGROUND: Metabolic tumor activity using 18F‐fluorodeoxyglucose positron emission
tomography (FDG‐PET) was believed to have a predictive value for patient outcome in …

The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer

H Kato, H Kimura, M Nakajima, M Sakai… - Oncology …, 2008 - spandidos-publications.com
The purpose of the present study was to assess the contribution of simultaneous
functional/anatomical imaging using integrated 18F-fluorodeoxyglucose-positron emission …

Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomography

H Kato, M Fukuchi, T Miyazaki, M Nakajima… - Anticancer …, 2007 - ar.iiarjournals.org
Background: Positron emission tomography (PET) with 18-F-fluorodeoxyglucose (FDG) has
already proven useful in assessing the extension of esophageal carcinomas, detecting …

Adverse prognostic factors of advanced esophageal cancer in patients undergoing induction therapy with docetaxel, cisplatin and 5-fluorouracil

M Nakajima, H Muroi, M Kikuchi, M Takahashi… - Anticancer …, 2018 - ar.iiarjournals.org
Background/Aim: The purpose of this study was to identify adverse prognostic factors for
patients with advanced esophageal cancer undergoing chemotherapy with docetaxel …

F-18 FDG PET/CT contributes to more accurate detection of lymph nodal metastasis from actively proliferating esophageal squamous cell carcinoma

S Tanabe, Y Naomoto, Y Shirakawa… - Clinical Nuclear …, 2011 - journals.lww.com
Purpose: Evaluating the status of disease progression is critical for planning a therapeutic
strategy for esophageal cancer. In this regard, F-18 fluorodeoxyglucose-labeled positron …

[HTML][HTML] Performance of 18-fluoro-2-deoxyglucose positron emission tomography for esophageal cancer screening

M Sekiguchi, T Terauchi, Y Kakugawa… - World Journal of …, 2017 - ncbi.nlm.nih.gov
AIM To evaluate the performance of 18-fluoro-2-deoxyglucose positron emission
tomography (FDG-PET) for esophageal cancer (EC) screening. METHODS We …

Роль позитронно-эмиссионной томографии, совмещенной с компьютерной томографией, в оценке эффективности лечения новообразований верхних …

ТР Конурбаев - Современные проблемы науки и образования, 2013 - elibrary.ru
На базе отделения радиоизотопной диагностики АО «Республиканского
диагностического центра» г. Астана в период с 2010 по 2012 гг. была проведена оценка …

ПЭТ/КТ как метод выявления частоты и локализации метастазов в лимфатических узлах после проведенного лечения у больных раком пищевода

АВ Важенин, ТР Конурбаев… - Тюменский …, 2013 - cyberleninka.ru
Злокачественные опухоли представляют большую медико-социальную проблему, при
этом уровень заболеваемости неуклонно растет [4]. Рак пищевода относится к числу …

The Role of PET-CT in the Clinical Management of Oesophageal Cancer

R Jeganathan, J McGuigan, T Lynch - Topics in Thoracic Surgery, 2012 - books.google.com
Oesophageal cancer, once a relatively rare form of cancer, with a non-uniform geographical
distribution, is the sixth most common cause of cancer related death in UK for 2005 (1-3). By …